MDRX vs. SPY
Compare and contrast key facts about Allscripts Healthcare Solutions, Inc. (MDRX) and State Street SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Performance
MDRX vs. SPY - Performance Comparison
Loading graphics...
MDRX vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MDRX Allscripts Healthcare Solutions, Inc. | -3.13% | -50.77% | -7.05% | -40.53% | -4.39% | 27.77% | 47.12% | 1.82% | -33.75% | 42.51% |
SPY State Street SPDR S&P 500 ETF | -3.65% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Returns By Period
In the year-to-date period, MDRX achieves a -3.12% return, which is significantly higher than SPY's -3.65% return. Over the past 10 years, MDRX has underperformed SPY with an annualized return of -10.15%, while SPY has yielded a comparatively higher 14.06% annualized return.
MDRX
- 1D
- 2.20%
- 1M
- -5.10%
- YTD
- -3.12%
- 6M
- -3.13%
- 1Y
- 6.65%
- 3Y*
- -29.11%
- 5Y*
- -21.24%
- 10Y*
- -10.15%
SPY
- 1D
- 0.75%
- 1M
- -4.28%
- YTD
- -3.65%
- 6M
- -1.42%
- 1Y
- 18.14%
- 3Y*
- 18.48%
- 5Y*
- 11.86%
- 10Y*
- 14.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDRX vs. SPY — Risk / Return Rank
MDRX
SPY
MDRX vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Allscripts Healthcare Solutions, Inc. (MDRX) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MDRX | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.13 | 0.96 | -0.83 |
Sortino ratioReturn per unit of downside risk | 0.56 | 1.49 | -0.93 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.23 | -0.15 |
Calmar ratioReturn relative to maximum drawdown | 0.49 | 1.53 | -1.04 |
Martin ratioReturn relative to average drawdown | 1.05 | 7.27 | -6.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MDRX | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.13 | 0.96 | -0.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.46 | 0.70 | -1.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.23 | 0.79 | -1.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.08 | 0.56 | -0.64 |
Correlation
The correlation between MDRX and SPY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MDRX vs. SPY - Dividend Comparison
MDRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.13%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDRX Allscripts Healthcare Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.13% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Drawdowns
MDRX vs. SPY - Drawdown Comparison
The maximum MDRX drawdown since its inception was -97.79%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for MDRX and SPY.
Loading graphics...
Drawdown Indicators
| MDRX | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.79% | -55.19% | -42.60% |
Max Drawdown (1Y)Largest decline over 1 year | -19.05% | -12.05% | -7.00% |
Max Drawdown (5Y)Largest decline over 5 years | -83.11% | -24.50% | -58.61% |
Max Drawdown (10Y)Largest decline over 10 years | -83.11% | -33.72% | -49.39% |
Current DrawdownCurrent decline from peak | -94.59% | -5.53% | -89.06% |
Average DrawdownAverage peak-to-trough decline | -83.01% | -9.09% | -73.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.96% | 2.54% | +6.42% |
Volatility
MDRX vs. SPY - Volatility Comparison
Allscripts Healthcare Solutions, Inc. (MDRX) has a higher volatility of 18.12% compared to State Street SPDR S&P 500 ETF (SPY) at 5.35%. This indicates that MDRX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MDRX | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.12% | 5.35% | +12.77% |
Volatility (6M)Calculated over the trailing 6-month period | 35.54% | 9.50% | +26.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.44% | 19.06% | +33.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.20% | 17.06% | +29.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.89% | 17.92% | +26.97% |